IP Library Granted Patent US 12,551,707
Granted Patent B2
US 12,551,707 · App. 17/857,085 · Granted Feb 17, 2026

Means and methods for using non-excitatory electrical heart failure therapy as a therapy for heart failure with preserved ejection fraction

Inventors: David Prutchi (Voorhees, NJ); Simeon Ioannis Kedikoglou (Tallahassee, FL); Tamir Ben David (Tel-Aviv, IL)
Assignee: Impulse Dynamics NV
A61N1/3628A61N1/36507A61N1/36571A61N1/36578
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,551,707
App. No.
17/857,085
Granted
Feb 17, 2026
Kind
B2
Abstract

The present invention relates to non-excitatory electrical heart failure therapy as a therapy for Heart failure with preserved ejection fraction.

Claims (13)

1 . A method of treating a patient with non-excitatory electrical heart failure therapy, the method comprising:

a. identifying a patient that suffers of heart failure (HF) and presents pulmonary capillary wedge pressure indexed to cardiac output (PCWP/CO) slope greater than 2 mm Hg/L/min;

b. implanting an implantable cardiac electrical stimulation device;

c. providing an effective amount of non-excitatory electrical heart failure therapy using said implantable cardiac electrical stimulation device;

wherein said providing is at least until said HF patient presents a reduction in said PCWP/CO slope and uses said PCWP/CO slope as a target for therapy.

2 . The method according to claim 1 , wherein said non-excitatory electrical heart failure therapy is cardiac contractility modulation therapy.

3 . The method according to claim 1 , wherein the HF condition is HF with preserved ejection fraction (pEF).

4 . The method according to claim 1 , wherein said patient has a hypertrophic right ventricle.

5 . The method according to claim 1 , wherein said patient has a hypertrophic ventricular septum.

6 . The method of claim 1 , wherein said providing is at least until said HF patient presents an increase in cardiac contractility.

7 . The method of claim 1 , wherein said providing is at least until said HF patient presents an increase in cardiac output.

8 . The method of claim 1 , wherein said providing is at least until said HF patient presents a reduction in arrhythmia level.

9 . The method of claim 1 , wherein said providing is at least until said HF patient presents a reduction in cardiac stiffness.

Assignments (2)
SECURITY INTEREST Recorded May 23, 2024
From: IMPULSE DYNAMICS, N.V.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 067526/0072 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2022
From: PRUTCHI, DAVID; KEDIKOGLOU, SIMEON IOANNIS; BEN DAVID, TAMIR
To: IMPULSE DYNAMICS NV
Reel/Frame 060680/0207 →